Tandem Diabetes Care, Inc.
General ticker "TNDM" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $1.4B (TTM average)
Tandem Diabetes Care, Inc. does not follow the US Stock Market performance with the rate: -3.2%.
Estimated limits based on current volatility of 3.3%: low 19.47$, high 20.79$
Factors to consider:
- Total employees count: 2650 (+10.4%) as of 2024
- US accounted for 71.5% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Manufacturing risks, Market competition, Cost increases, Geopolitical risks, Labor/talent shortage/retention
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [17.38$, 45.10$]
- 2025-12-31 to 2026-12-31 estimated range: [14.19$, 37.74$]
Financial Metrics affecting the TNDM estimates:
- Negative: with PPE of -18.9 at the end of fiscal year the price was high
- Negative: negative Operating income
- Positive: 0.33 < Operating cash flow per share per price, % of 1.03
- Positive: Inventory ratio change, % of -0.44 <= 0
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Positive: Interest expense per share per price, % of 0.32 <= 0.79
- Positive: 18.93 < Shareholder equity ratio, % of 27.19 <= 41.86
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
Short-term TNDM quotes
Long-term TNDM plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $801.22MM | $747.72MM | $940.20MM |
| Operating Expenses | $894.07MM | $980.95MM | $1,039.33MM |
| Operating Income | $-92.85MM | $-233.23MM | $-99.13MM |
| Non-Operating Income | $-0.00MM | $12.98MM | $7.26MM |
| Interest Expense | $6.21MM | $9.88MM | $7.42MM |
| R&D Expense | $170.15MM | $248.42MM | $198.88MM |
| Income(Loss) | $-92.85MM | $-220.25MM | $-91.87MM |
| Taxes | $1.74MM | $2.36MM | $4.16MM |
| Profit(Loss)* | $-94.59MM | $-222.61MM | $-96.03MM |
| Stockholders Equity | $439.95MM | $313.63MM | $263.10MM |
| Inventory | $111.12MM | $157.94MM | $149.61MM |
| Assets | $1,052.79MM | $952.66MM | $967.66MM |
| Operating Cash Flow | $50.46MM | $-31.81MM | $24.23MM |
| Capital expenditure | $34.10MM | $26.80MM | $19.23MM |
| Investing Cash Flow | $33.17MM | $-85.74MM | $-23.48MM |
| Financing Cash Flow | $16.88MM | $4.11MM | $8.37MM |
| Earnings Per Share** | $-1.47 | $-3.43 | $-1.47 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.